Protocol

Postmarketing Commitment Safety Study of HZ/su to Evaluate Pregnancy Exposures and Outcomes in Immunodeficient or Immunosuppressed Women Between 18 and 49 Years of Age

March 31, 2023
Authors:

Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Optum Epidemiology, GlaxoSmithKline

Capability:
Pregnancy & Mother-Infant Linked Studies
Multi-Site Methods & Coordination
Expertise:
Regulatory Research & Support
RWE Research & Consulting
Home
Publications
Postmarketing Commitment Safety Study of HZ/su to Evaluate Pregnancy Exposures and Outcomes in Immunodeficient or Immunosuppressed Women Between 18 and 49 Years of Age
...
View the public protocol
CONTACT US

© Real-World Evidence Practice. All rights reserved.

Harvard Pilgrim Health Care Institute Department of Population Medicine
Privacy Policy